INTS vs PFE
Intensity Therapeutics, Inc. Common stock (INTS) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
INTS does not have a complete income-statement cache yet.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
INTS currently screens at market cap $7.7M. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the INTS and PFE stock pages for the full models.
Not investment advice.